Loading...
Fetching results...
0 items found

Pembrolizumab (pembro) as adjuvant therapy for patients (pts) with renal cell carcinoma (RCC): Updated results from the 30-month follow-up of KEYNOTE-564

Presenter

Speaker
T. Powles, London (GB)
Event
37th Annual EAU Congress
Date – Time - Location
01 July 2022, 07:30 - 08:00, Grey Area, eURO Auditorium 2
Session
Game changing session - Game changing session 2
  • © 2022 European Association of Urology
  • Disclaimer